부산대학교 도서관

Antonarakis, ES; Piulats, JM; Gross-Goupil, M; Goh, J; Ojamaa, K; Hoimes, CJ; Vaishampayan, U; Berger, R; Sezer, A; Alanko, T; de Wit, R; Li, CD; Omlin, A; Procopio, G; Fukasawa, S; Tabata, KI; Park, SH; Feyerabend, S; Drake, CG; Wu, HY; Qiu, P; Kim, J; Poehlein, C; de Bono, JS

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38(5):395-405

Antonarakis, ES; Piulats, JM; Gross-Goupil, M; Goh, JC; Vaishampayan, UN; De Wit, R; Alanko, TV; Fukasawa, S; Tabata, K; Feyerabend, S; Berger, R; Ojamaa, K; Hoimes, CJ; Sezer, A; Omlin, AG; Yachnin, J; Niu, C; Poehlein, CH; Schloss, C; de Bono, JS

ANNALS OF ONCOLOGY. 32:S651-S652

Merl, MY; Hoimes, CJ; Pham, T; Saif, M Wasif

Expert Opinion on Investigational Drugs; September 2009, Vol. 18 Issue: 9 p1257-1264, 8p

Antonarakis, E.S.; Piulats, J.M.; Gross-Goupil, J.; Ojamaa, K.; Hoimes, CJ.

In: Cancer Discovery. (Cancer Discovery, January 2020, 10(1):15)

Hoimes CJ; Selbst MK; Shafi NQ; Rose MG; Rosado MF; Hoimes, Christopher J; Selbst, Megan K; Shafi, Nelofar Q; Rose, Michal G; Rosado, Manuel F

Journal of Clinical Oncology (J CLIN ONCOL), 1/10/2010; 28(2): e11-3. (1p)

Milowsky MI; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.; O'Donnell PH; University of Chicago, Chicago, IL.; Hoimes CJ; Duke Cancer Institute, Duke University, Durham, NC.; Petrylak DP; Yale Cancer Center, New Haven, CT.; Flaig TW; University of Colorado Comprehensive Cancer Center, Aurora, CO.; Moon HH; Kaiser Permanente Southern California, Riverside, CA.; Friedlander TW; University of California San Francisco Medical Center, San Francisco, CA.; Mar N; University of California Irvine, Irvine, CA.; McKay RR; University of California San Diego, San Diego, CA.; Srinivas S; Stanford University Medical Center, Stanford, CA.; Gravis G; Institut Paoli-Calmettes, Marseille, France.; Ramamurthy C; MD Anderson Cancer Center, University of Texas Health, San Antonio, TX.; Bupathi M; Rocky Mountain Cancer Centers, Littleton, CO.; Bracarda S; Azienda Ospedaliera Santa Maria Terni, Terni, Italy.; Wright P; Seagen Inc, Bothell, WA.; Hepp Z; Seagen Inc, Bothell, WA.; Carret AS; Seagen Inc, Bothell, WA.; Yu Y; Seagen Inc, Bothell, WA.; Dillon R; Astellas Pharma Inc, Northbrook, IL.; Kataria R; Merck & Co, Inc, Rahway, NJ.; Beaumont JL; Clinical Outcomes Solutions Ltd, Tucson, AZ.; Purnajo I; Clinical Outcomes Solutions Ltd, Tucson, AZ.; Rosenberg JE; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Fletcher K; Vanderbilt University School of Medicine, Nashville, USA. Electronic address: kylie.a.fletcher@vanderbilt.edu.; Cortellini A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Roma, Italy; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom.; Ganta T; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Kankaria R; Vanderbilt University School of Medicine, Nashville, USA.; Song H; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.; Ye F; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.; Irlmeier R; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.; Debnath N; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Saeed A; Division of Hematology & Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Radford M; University of Iowa Healthcare, Iowa City, IA, USA.; Alahmadi A; Case Western Reserve University, Division of Hematology & Oncology, Cleveland, OH, USA; Ohio State University, The James Comprehensive Cancer Center, Columbus.; Diamond A; Case Western Reserve University, Division of Hematology & Oncology, Cleveland, OH, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.; Hoimes C; Case Western Reserve University, Division of Hematology & Oncology, Cleveland, OH, USA; Duke Cancer Institute, Duke University, Durham, NC, USA.; Presley CJ; Ohio State University, The James Comprehensive Cancer Center, Columbus.; Owen DH; Ohio State University, The James Comprehensive Cancer Center, Columbus.; Abou Alaiwi S; Yale New Haven Hospital, Yale School of Medicine, New Haven, CT, USA.; Nassar AH; Yale New Haven Hospital, Yale School of Medicine, New Haven, CT, USA.; Lamberti G; Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.; Perrone F; Medical Oncology Unit, University Hospital of Parma and Medicine and Surgery Department, University of Parma, Parma, Italy.; Buti S; Medical Oncology Unit, University Hospital of Parma and Medicine and Surgery Department, University of Parma, Parma, Italy.; Giusti R; Medical Oncology Unit, Azienda Ospedaliero Universitaria Sant'Andrea, Rome, Italy.; Filetti M; Phase 1 Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.; Vanella V; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.; Mallardo D; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.; Sussman TA; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.; Galetta D; IRCCS Istituto Tumori Giovanni Paolo II, Medical Thoracic Oncology Unit, Bari, Italy.; Kalofonou F; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Daniels E; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.; Pinato DJ; Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Department of Translational Medicine, University of Piemonte Orientale 'A. Avogadro', Novara, Italy.; Nebhan C; Intermountain Health, Murray UT, USA.; Berg S; Dana-Farber Cancer Institute, Boston, MA, USA.; Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA.; Marron TU; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Wang Y; The University of Texas MD Anderson Cancer Center, Houston.; Naqash AR; Medical Oncology/TSET Phase 1 Program, Stephenson Cancer Center, University of Oklahoma, Oklahoma City, USA.; Johnson DB; Department of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: douglas.b.johnson@vumc.org.

Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

Hoimes CJ; Duke Cancer Institute; Duke University, Durham, NC, USA.; Flaig TW; University of Colorado Comprehensive Cancer Center, Aurora, CO, USA.; Milowsky MI; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.; Friedlander TW; University of California San Francisco Medical Center, San Francisco, CA, USA.; Bilen MA; Winship Cancer Institute of Emory University, Hematology & Medical Oncology, Atlanta, GA, USA.; Gupta S; Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.; Srinivas S; Stanford University Medical Center, Stanford, CA, USA.; Merchan JR; University of Miami, Medical Oncology, Miami, FL, USA.; McKay RR; University of California San Diego Moores Cancer Center, San Diego, CA, USA.; Petrylak DP; Yale Comprehensive Cancer Center, New Haven, CT, USA.; Sasse C; Astellas Pharma Global Development, Northbrook, IL, USA.; Moreno BH; Merck & Co., Inc., Rahway, NJ, USA.; Yu Y; Seagen Inc., Bothell, WA, USA.; Carret AS; Seagen Inc., Bothell, WA, USA.; Rosenberg JE; Memorial Sloan Kettering Cancer Center & Weill Cornell Medical College, New York, NY, USA.

Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

Msaouel P; University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: PMsaouel@mdanderson.org.; Sweis RF; University of Chicago Medicine, Chicago, IL, USA.; Bupathi M; Rocky Mountain Cancer Centers - Littleton, Littleton, CO, USA.; Heath E; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.; Goodman OB Jr; Comprehensive Cancer Centers of Nevada - Southwest, Las Vegas, NV, USA.; Hoimes CJ; Duke University Hospital, Durham, NC, USA.; Milowsky MI; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.; Davis N; Vanderbilt - Ingram Cancer Center, Nashville, TN, USA.; Kalebasty AR; University of California Irvine, Irvine, CA, USA.; Picus J; Washington University School of Medicine, Siteman Cancer Center, Saint Louis, MO, USA.; Shaffer D; New York Oncology Hematology - Albany Medical Center, Albany, NY, USA.; Mao S; Allegheny General Hospital, Pittsburgh, PA, USA.; Adra N; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.; Yorio J; Texas Oncology - Austin Central, Austin, TX, USA.; Gandhi S; Florida Cancer Specialists and Research Institute - North Region (SCRI), Tampa Bay, FL, USA.; Grivas P; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA.; Siefker-Radtke A; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yang R; Mirati Therapeutics, Inc., San Diego, CA, USA.; Latven L; Mirati Therapeutics, Inc., San Diego, CA, USA.; Olson P; Mirati Therapeutics, Inc., San Diego, CA, USA.; Chin CD; Mirati Therapeutics, Inc., San Diego, CA, USA.; Der-Torossian H; Mirati Therapeutics, Inc., San Diego, CA, USA.; Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, OH, USA.; Iyer G; Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Moore EC; Tempus Labs, Inc, Chicago, Illinois, USA.; Blobe GC; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA.; DeVito NC; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.; Center for Cancer Immunotherapy, Duke University Medical Center, Durham, North Carolina, USA.; Hanks BA; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA.; Center for Cancer Immunotherapy, Duke University Medical Center, Durham, North Carolina, USA.; Harrison MR; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina, USA.; Hoimes CJ; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.; Center for Cancer Immunotherapy, Duke University Medical Center, Durham, North Carolina, USA.; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina, USA.; Jia J; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.; Morse MA; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.; Jayaprakasan P; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.; MacKelfresh A; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.; Mulder H; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.; Hockenberry AJ; Tempus Labs, Inc, Chicago, Illinois, USA.; Zander A; Tempus Labs, Inc, Chicago, Illinois, USA.; Stumpe MC; Tempus Labs, Inc, Chicago, Illinois, USA.; Michuda J; Tempus Labs, Inc, Chicago, Illinois, USA.; Beauchamp KA; Tempus Labs, Inc, Chicago, Illinois, USA.; Perakslis E; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.; Taxter T; Tempus Labs, Inc, Chicago, Illinois, USA.; George DJ; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina, USA.

Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE